摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(溴甲基)苯基氨基甲酸叔丁酯 | 166329-43-7

中文名称
2-(溴甲基)苯基氨基甲酸叔丁酯
中文别名
——
英文名称
N-tert-butoxycarbonyl-2-bromomethylaniline
英文别名
[2-[N-(tert-butoxycarbonyl)amino]phenyl]methyl bromide;2-(tert-butyloxycarbonyl)aminobenzyl bromide;N-(tert-butoxycarbonyl)-2-bromomethylaniline;tert-butyl (2-(bromomethyl)-phenyl)carbamate;tert-butyl (2-(bromomethyl)phenyl)carbamate;2-bromomethyl-N-tert-butoxycarbonylaniline;tert-butyl N-[2-(bromomethyl)phenyl]carbamate
2-(溴甲基)苯基氨基甲酸叔丁酯化学式
CAS
166329-43-7
化学式
C12H16BrNO2
mdl
——
分子量
286.169
InChiKey
RRLOJNBCMQJDHS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    309.0±25.0 °C(Predicted)
  • 密度:
    1.376±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    16
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    38.3
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2924299090
  • 包装等级:
    III
  • 危险类别:
    6.1
  • 危险性防范说明:
    P280,P305+P351+P338,P310
  • 危险品运输编号:
    2811
  • 危险性描述:
    H301

SDS

SDS:892840bc232275ba0ccf3eea12e243b4
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-Boc-aminobenzyl bromide
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2-Boc-aminobenzyl bromide
CAS number: 166329-43-7

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C12H16BrNO2
Molecular weight: 286.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    通过苯胺-炔烃的分子内加氢和不对称加氢合成手性苯并-N-杂环的合成路线
    摘要:
    已经报道了在单一手性钌配合物或由非手性金配合物和手性钌配合物组成的二元体系的催化下有效的顺序分子内加氢/不对称氢化反应。从苯胺衍生物获得了多种对映体富集的苯并稠合的N-杂环,包括1,2,3,4-四氢喹啉,二氢吲哚和2,3,4,5-四氢-1 H-苯并[ b ] pine庚因衍生物-炔烃在温和条件下具有高产率(高达98%)和中等至优异的对映选择性(高达98%ee)。该协议具有良好的官能团耐受性和较高的原子经济性。此外,该催化方案适用于天然存在的生物碱(-)-Angustureine的克规模合成。
    DOI:
    10.1021/acs.organomet.9b00183
  • 作为产物:
    描述:
    参考文献:
    名称:
    光氧化还原催化的三氟甲基化分子内环化:含CF 3杂环化合物的合成。
    摘要:
    开发了一种一般的光氧化还原催化的分子内环化反应,用于合成三氟甲基化的杂环化合物。反应在温和的光催化条件下以高官能团耐受性顺利进行,可以制备不同大小的含氧,硫或氮的杂环。广泛的底物范围证明了该策略在提高复杂性方面的潜力。
    DOI:
    10.1021/acs.orglett.8b00648
点击查看最新优质反应信息

文献信息

  • Indoles
    申请人:Eisai Co., Ltd.
    公开号:US20020019531A1
    公开(公告)日:2002-02-14
    A 1,4-substituted cyclic amine derivative represented by the following formula or a pharmacologically acceptable salt thereof: 1 wherein A, B, C, D, T, Y, and Z each represent a methine or a nitrogen linkage; R 1 , R 2 , R 3 , R 4 , and R 5 each represent a substituent; n represents 0 or an integer of 1 to 3; m represents 0 or an integer of 1 to 6; and p represents an integer of 1 to 3. The compounds have serotonin antagonism. They are therefore clinically useful as medicaments, in particular, for treating, ameliorating, and preventing spastic paralysis. They are also useful as central muscle relaxants for ameliorating myotonia.
    一种由以下公式表示的1,4-取代的环胺衍生物或其药理学上可接受的盐: 其中A、B、C、D、T、Y和Z分别表示亚甲基或氮键合物;R1、R2、R3、R4和R5分别表示取代基;n表示0或1至3的整数;m表示0或1至6的整数;p表示1至3的整数。这些化合物具有5-羟色胺拮抗作用。因此,在临床上作为药物特别有用,用于治疗、改善和预防痉挛性瘫痪。它们还可用作中枢肌肉松弛剂,改善肌张力过高。
  • Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, process for preparing them, medicaments comprising these compounds, and their use
    申请人:JAEHNE Gerhard
    公开号:US20090215728A1
    公开(公告)日:2009-08-27
    This invention relates to arylaminoaryl-alkyl-substituted imidazolidone-2,4-diones of formula (I) and also to their physiologically tolerated salts: Wherein R, R′, R1 to R10, A, D, E, G, L and p are as defined herein. The invention also relates to processes for preparing them, pharmaceutical compositions comprising them and their therapeutic use. The compounds are suitable, for example, as anti-obesity drugs and for treating cardiometabolic syndrome.
    这项发明涉及公式(I)中的芳基氨基芳基烷基取代的咪唑烷二酮及其生理耐受的盐: 其中R、R'、R1至R10、A、D、E、G、L和p如本文所定义。该发明还涉及制备它们的方法、包含它们的药物组合物以及它们的治疗用途。这些化合物适用于例如作为抗肥胖药物和治疗心脏代谢综合征。
  • Dibromo-BODIPY as an Organic Photocatalyst for Radical–Ionic Sequences
    作者:William H. García-Santos、Javier Ordóñez-Hernández、Mónica Farfán-Paredes、Hiram M. Castro-Cruz、Norma A. Macías-Ruvalcaba、Norberto Farfán、Alejandro Cordero-Vargas
    DOI:10.1021/acs.joc.1c01598
    日期:2021.12.3
    A new dibrominated 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY) is reported as a new metal-free photocatalyst. This BODIPY showed similar optoelectronic, electrochemical, and performance properties to those of Ru(bpy)3Cl2, one of the most common photocatalysts in a known radical–ionic transformation, such as the formation of 1,4-dicarbonyl compounds. Moreover, additional sequences in which the
    一种新的二溴化 4,4-二氟-4-bora-3a,4a- diaza - s - indacene (BODIPY) 被报道为一种新的无金属光催化剂。该 BODIPY 显示出与 Ru(bpy) 3 Cl 2相似的光电、电化学和性能特性,Ru(bpy) 3 Cl 2是已知自由基 - 离子转化(例如形成 1,4-二羰基化合物)中最常见的光催化剂之一。此外,使用这种 BODIPY 光催化剂开发了额外的序列,其中生成的氧离子被内部亲核试剂捕获。这些新序列允许直接制备 γ-烷氧基内酯、单保护的 1,4-酮醛和二氢呋喃。这种新的催化剂、方法和伪造的官能团可能是有机合成中的重要工具。
  • Construction of Azacycles Based on Endo-Mode Cyclization of Allenes
    作者:Chisato Mukai、Minoru Kobayashi、Shoko Kubota、Yukie Takahashi、Shinji Kitagaki
    DOI:10.1021/jo035729f
    日期:2004.3.1
    procedure for constructing monocyclic five- and six-membered azacycles by the endo-mode ring-closing reaction of allenylazido derivatives under neutral conditions has been developed. The azabicyclo[m.n.0] compounds were prepared by applying this newly developed procedure. The seven-membered azacycle was prepared when the allene possessing an unsubstituted carboxyl amido functionality was submitted
    已开发出一种在中性条件下通过烯丙基叠氮基衍生物的内模闭环反应构建单环五元和六元氮杂环的新方法。氮杂双环[ m。Ñ通过施加该新开发的方法制备0.0]的化合物。当具有未取代的羧基酰胺基官能团的丙二烯经受基本条件时,制备了七元氮杂环。另外,使用该方法合成了吲哚和喹啉骨架。
  • Synthesis of 1,4-benzodiazepine-1-carbothioamides, bicyclic analogues of the TIBO-type anti-HIV agents
    作者:Jie Liu、Robert H. Dodd
    DOI:10.1002/jhet.5570320225
    日期:1995.3
    series of N'-substituted 1,4-benzodiazepine-1-carbothioamides 2a-j were prepared by reacting the precursor 1,4-benzodiazepine 11 with the corresponding N-substituted isothiocyanates 2a-i or with sodium thiocyanate-trifluoroacetic acid (2j). Despite the structural ressemblance of these molecules with the potent TIBO-type anti-HIV compound R82150, 2a-j displayed no anti-HIV activity in vitro.
    一系列的N” -取代的1,4-苯并二氮杂-1- carbothioamides 2a-j中是由前体1,4-苯并二氮杂反应制备11与相应的Ñ取代异硫氰酸酯2A-I或与硫氰酸钠,三氟乙酸(2J )。尽管这些分子与有效的TIBO型抗HIV化合物R82150具有结构相似性,但2a-j在体外没有显示抗HIV活性。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐